Here’s How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 15 Years

Article summary

Regeneron Pharmaceuticals (NASDAQ:REGN) has outperformed the market over the past 15 years by 4.59% on an annualized basis producing an average annual return of 17.79%. Currently, Regeneron Pharmaceuticals has a market